MegriƱo, Novyhl Mae B.

HRN: 24-33-29  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/20/2026
METRONIDAZOLE 500MG (TAB)
07/20/2026
07/26/2026
PO
500 Mg
TID
Thickly MSAF
Checking Final Appropriateness 

Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: